NUVB - Wall Street Estimates - Nuvation Bio Inc.

Healthcare - Biotechnology - NYSE - US

$ 1.98

0.508 %

$ 666 M

Market Cap

-0.91

P/E

Price Target Average

253.54%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

30.75%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Nuvation Bio Inc.

Wall Street analysts predict an average 1-year price target for NUVB of $7 , with forecasts ranging from a low of $5 to a high of $10 .

NUVB Lowest Price Target Wall Street Target

5 USD 152.53%

NUVB Average Price Target Wall Street Target

7 USD 253.54%

NUVB Highest Price Target Wall Street Target

10 USD 405.05%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free